{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 11
    }
  },
  "results": [
    {
      "update_type": "Reverified",
      "initial_posting_date": "09/05/2018",
      "package_ndc": "0641-6044-25",
      "generic_name": "Lorazepam Injection",
      "contact_info": "800-631-2174",
      "availability": "Limited Availability",
      "related_info": "Lots are being manufactured to meet demand",
      "openfda": {
        "application_number": [
          "NDA018140"
        ],
        "brand_name": [
          "LORAZEPAM"
        ],
        "generic_name": [
          "LORAZEPAM"
        ],
        "manufacturer_name": [
          "Hikma Pharmaceuticals USA Inc."
        ],
        "product_ndc": [
          "0641-6044",
          "0641-6046",
          "0641-6045",
          "0641-6047"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAMUSCULAR",
          "INTRAVENOUS"
        ],
        "substance_name": [
          "LORAZEPAM"
        ],
        "rxcui": [
          "238100",
          "238101",
          "1665188",
          "1665326"
        ],
        "spl_id": [
          "7c73dbc6-2623-4443-9b05-97dec7a0be2e"
        ],
        "spl_set_id": [
          "e9b54e42-04cf-4c62-90e1-36f7b31a4e81"
        ],
        "package_ndc": [
          "0641-6044-01",
          "0641-6044-25",
          "0641-6046-01",
          "0641-6046-10",
          "0641-6045-01",
          "0641-6045-25",
          "0641-6047-01",
          "0641-6047-10"
        ],
        "nui": [
          "N0000175694",
          "M0002356"
        ],
        "pharm_class_epc": [
          "Benzodiazepine [EPC]"
        ],
        "pharm_class_cs": [
          "Benzodiazepines [CS]"
        ],
        "unii": [
          "O26FZP769L"
        ]
      },
      "update_date": "08/13/2026",
      "therapeutic_category": [
        "Neurology"
      ],
      "dosage_form": "Injection",
      "presentation": "Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25)",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "shortage_reason": "Demand increase for the drug",
      "status": "Current"
    }
  ]
}